2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4365):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-23154
    9-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-amine
    		99.24%
    9-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-amine is a drug intermediate for synthesis of various active compounds.
    9-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-amine
  • HY-W019306
    N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline (hydrochloride)
    N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline hydrochloride is a molecular building block that can be used for the synthesis of other active compounds.
    N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline (hydrochloride)
  • HY-401031
    3-Bromo-2-hydroxy-4-methoxybenzaldehyde
    3-Bromo-2-hydroxy-4-methoxybenzaldehyde is a drug intermediate for synthesis of various active compounds.
    3-Bromo-2-hydroxy-4-methoxybenzaldehyde
  • HY-W001943
    3-Benzoylpropionic acid
    		99.97%
    3-Benzoylpropionic acid can be used as an intermediate in organic synthesis for the preparation of other organic compounds.
    3-Benzoylpropionic acid
  • HY-42466
    tert-Butyl ((R)-1-(5-((S)-1-amino-3-oxo-3-(tritylamino)propyl)-1,2,4-oxadiazol-3-yl)-2-(tert-butoxy)ethyl)carbamate
    tert-Butyl ((R)-1-(5-((S)-1-amino-3-oxo-3-(tritylamino)propyl)-1,2,4-oxadiazol-3-yl)-2-(tert-butoxy)ethyl)carbamate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl ((R)-1-(5-((S)-1-amino-3-oxo-3-(tritylamino)propyl)-1,2,4-oxadiazol-3-yl)-2-(tert-butoxy)ethyl)carbamate
  • HY-43656
    Methyl 2-amino-4-morpholinobenzoate
    		99.78%
    Methyl 2-amino-4-morpholinobenzoate is a drug intermediate for synthesis of various active compounds.
    Methyl 2-amino-4-morpholinobenzoate
  • HY-W015329
    3-Amino-1-adamantanol
    		99.66%
    3-Amino-1-adamantanol is an intermediate. 3-Amino-1-adamantanol can be used to synthesize compounds such as Vildagliptin (HY-14291).
    3-Amino-1-adamantanol
  • HY-W028714
    2,3-Diphenylquinoxaline-6-carboxylic acid
    		99.95%
    2,3-Diphenylquinoxaline-6-carboxylic acid is used for end-capping in the synthesis of AB2 monomers, which facilitates the synthesis and chain-end modification of hyperbranched polymers containing alternating quinoxaline and benzoxazole repeating units.
    2,3-Diphenylquinoxaline-6-carboxylic acid
  • HY-B1084
    Cinoctramide
    		99.06%
    Cinoctramide is an intermediate of pharmaceutical synthesis. Cinoctramide can be used for the research of autoimmune diseases.
    Cinoctramide
  • HY-21242
    MMT-hexylaminolinker phosphoramidite
    		98.0%
    MMT-Hexylaminolinker Phosphoramidite is a degradable linker and aminoalkylphosphoramidite monomer that can be used for the synthesis of oligonucleotide gap sequences or other nucleic acid molecules.
    MMT-hexylaminolinker phosphoramidite
  • HY-W077634
    3-Amino-5-hydroxybenzoic acid
    		99.83%
    3-Amino-5-hydroxybenzoic acid is a biosynthetic precursor of the mC7N unit of ansamycin antibiotics, including ansatrienin A and geldanamycin, as well as the antitumor antibiotic mitomycin C. 3-Amino-5-hydroxybenzoic acid may be an early intermediate in the shikimic acid pathway from glucose.
    3-Amino-5-hydroxybenzoic acid
  • HY-20344
    5-Ethynylindane
    		99.10%
    5-Ethynylindane is a drug intermediate for synthesis of various active compounds.
    5-Ethynylindane
  • HY-W098192
    Rivaroxaban impurity 1
    		98.47%
    Rivaroxaban impurity 1 is an impurity of Rivaroxaban (HY-50903).
    Rivaroxaban impurity 1
  • HY-W103288
    Oxcarbazepine impurity 2
    Oxcarbazepine impurity 2 is an impurity of Oxcarbazepine.
    Oxcarbazepine impurity 2
  • HY-164170
    Photocaged DAP
    		98.13%
    Photocaged DAP (pm-DAP) is a protected version of 2,3-Diaminopropionic acid (DAP) (HY-W013673). Photocaged DAP can produce 2,3-Diaminopropionic acid after photodeprotection. Photocaged DAP can be used as an intermediate to capture biosynthetic acylase.
    Photocaged DAP
  • HY-W047496
    AN-12-H5 intermediate-2
    AN-12-H5 intermediate-2 is an intermediate of the viral inhibitor AN-12-H5 (HY-120900) and can be used to synthesize Antibody-Drug Conjugates (ADCs).
    AN-12-H5 intermediate-2
  • HY-W053519
    DL-Pantolactone
    		99.30%
    DL-Pantolactone is a γ-lactone that can be hydrolyzed to Pantoic acid (HY-W399035) by the lactonohydrolase of Fusarium oxysporum. DL-Pantolactone also can be used in the preparation of 3,5-dinitrobenzoyl-DL-pantolactone.
    DL-Pantolactone
  • HY-32206
    Ribociclib impurity 5
    Ribociclib impurity 5 (OTAVA-BB 1314167) is an impurity of Ribociclib.
    Ribociclib impurity 5
  • HY-W319254
    2-(Pyridin-2-yl)benzo[d]oxazol-5-amine
    2-(Pyridin-2-yl)benzo[d]oxazol-5-amine is a drug intermediate for synthesis of various active compounds.
    2-(Pyridin-2-yl)benzo[d]oxazol-5-amine
  • HY-42543
    Ribociclib impurity 3
    		99.94%
    Ribociclib impurity 3 (Ribociclib impurity C) is an impurity of Ribociclib.
    Ribociclib impurity 3